A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia
Overview
- Phase
- Phase 1
- Intervention
- Room air
- Conditions
- Pulmonary Hypertension
- Sponsor
- Duke University
- Enrollment
- 10
- Locations
- 11
- Primary Endpoint
- Change daily hypoxemia burden
- Status
- Not yet recruiting
- Last Updated
- 8 months ago
Overview
Brief Summary
The purpose of this study is to assess the feasibility of supplemental oxygen delivery during hemodialysis in people with pulmonary hypertension and intradialytic hypoxemia.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults ≥18 years
- •Receiving Monday-Wednesday-Friday or Tuesday-Thursday-Saturday hemodialysis
- •Screened positive for pulmonary hypertension (defined by tricuspid regurgitant velocity \[TRV\] \>2.5 m/s on echocardiography) and intradialytic hypoxemia (defined by spending ≥1/3 treatment with O2 saturation \<90%) or hypoxemia for ≥10% of the treatment if associated with a desaturation event (≥4% decline in O2 saturation to \<88% for ≥10 seconds) during enrollment in the PH-ESKD study (Pro00108710).
Exclusion Criteria
- •Daily supplemental oxygen use
- •Inability to provide informed consent
Arms & Interventions
Room air
Participants will receive no supplemental oxygen.
Intervention: Room air
Supplemental oxygen (0.5 liters per minute)
Participants will receive supplemental oxygen by oxygen concentrator delivered by nasal cannula at 0.5 liters per minute.
Intervention: Oxygen
Supplemental oxygen (3 liters per minute)
Participants will receive supplemental oxygen by oxygen concentrator delivered by nasal cannula at 3 liters per minute.
Intervention: Oxygen
Outcomes
Primary Outcomes
Change daily hypoxemia burden
Time Frame: Weeks 1, 2, and 3
Minutes with oxygen saturation \<90% over a 24-hour period assessed by pulse oximetry
Secondary Outcomes
- Change in six minute walk distance(Weeks 1 and 3)
- Change in Montreal Cognitive Assessment (MoCA)(Weeks 1 and 3)